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OBJECTIVES: Evaluate the degree of vascular occlusion, vascular recanalization, and necrosis of the vascular wall caused by 
polyvinyl alcohol-covered polyvinyl acetate (PVAc) particles compared to trisacryl particles after renal embolization. 
METHODS: Seventy-nine female albino New Zealand rabbits underwent arterial catheterization of the right kidney. Thirty-three 
animals were embolized with trisacryl particles, thirty-one with PVAc particles, and fifteen were kept as controls. Four animals 
were excluded (three trisacryl and one PVAc) due to early death. Five subgroups of six animals were created. The animals in the 
different groups were sacrificed either 48 hours, 5 days, 10 days, 30 days, or 90 days after embolization. The control group was 
divided into subgroups of three animals each and kept for the same periods of time. The kidneys were dyed with hematoxylin-eosin 
and Masson’s trichrome and then examined using optical microscopy.
RESULTS: There were significant differences in the degree of vascular occlusion caused by the trisacryl and the PVAc particles 
between the five-day and the ten-day groups. Additional differences were noted between the five-day and 48-hour groups in regard 
to the amount of necrosis. For both findings, the PVAc group members showed adequate tissue reaction (ischemia and volumetric 
reduction) and less recanalization than those treated with trisacryl.
CONCLUSION: The use of PVAc as an embolization material exhibited an adequate tissue reaction (ischemia and volumetric 
reduction), more expressive vascular occlusion and necrosis, and less recanalization than the trisacryl material. 
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INTRODUCTION
Endovascular embolization is a very important strategy 
in the treatment of tumors and arteriovenous malformations 
(AVMs).1,3 This technique is based on the injection of a 
synthetic material after selective catheterization of the blood 
vessels that irrigate the region being treated. The synthetic 
material interrupts the supply of nutrients to this particular 
region, leading to necrosis and a decrease in size of the 
organ. Thus, embolization favors the recovery of the tissue 
after a variable amount of time.
Different materials have been proposed to be used for 
vascular occlusion through embolization. Latchaw and 
Gold mention the use of metal coils, silicon rubber, carbon 
microspheres, and polyvinyl alcohol particles as suitable 
materials for embolization.2 In each case, one should 
consider the compatibility between the size of the material to 
be injected, the diameter of the catheter used, the vessels to 
be treated, and the suitability of the material for sterilization.
Among  the  above-mentioned  materials,  vinyl 
polyalcohol, or polyvinyl alcohol (PVA), deserves special 
attention because of its many interesting properties. 
The interesting properties of PVA include elevated 
compressibility, good elasticity, and good chemical 
resistance to acids, bases, and detergents.1 In fact, PVA 
foams have the ability to resume their original shape 1106
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after compression when they are exposed to blood. 
This property makes PVA a very appealing material for 
embolization because the size of the catheter limits the size 
of the particles. Unfortunately, currently available PVA has 
some undesirable aspects. First, the flake-like shape and 
very uneven surfaces of PVA particles4,5 facilitates their 
agglutination and aggregation, making their flow through 
a catheter very difficult.6,7 In addition, currently available 
PVA is prone to degradation over time (biodegradability), 
increasing the possibility of future recanalization of the 
treated vessels. 
In recent years, several sources have used spherical 
embolization agents. These spherical agents are easier to 
use and more effective at promoting vascular occlusion 
compared to non-spherical agents.8,9 An advantage of 
spherical particles is their defined size and the ability to 
calibrate particle size. Previous studies have demonstrated 
that particles with diameters closely matched to the vessels 
targeted for occlusion make the embolization procedure safer 
and more accurate.10 Spherical PVA and trisacryl are among 
several spherical agents that have already been produced and 
tested for medical use.10,11
Several trials were undertaken in the Chemical 
Engineering program of the Group of Research on 
Engineering (COPPE) of the Federal University of Rio de 
Janeiro (UFRJ). The aims of these trials were to produce 
a new spherical particle using alternative initializing 
mechanisms, such as ionizing ultraviolet light,12 and 
to suggest new viable routes for synthesizing PVA that 
can be used as an embolizing agent. Some of the classic 
polymerization procedures for vinyl acetate (a precursor of 
polyvinyl alcohol) under heating were considered, followed 
by hydrolysis through basic solutions and purification steps, 
as well as the polymerization of vinyl acetate in ultraviolet 
chambers. The aim of these new techniques was to control of 
the amount of ramification in the polyvinyl acetate leading to 
the generation of a spherical particle that consists of a core 
of polyvinyl acetate coated by PVA produced according to 
the technique published by Peixoto et al.13
The objective of this study was to evaluate the effects of 
arterial embolization with trisacryl and PVAc particles in the 
kidneys of albino New Zealand rabbits. The effect of these 
particles was measured by the degree of vascular occlusion, 
the extent of necrosis of the vascular wall, and the presence 
of recanalization of the vessel lumen.
MATERIALS AND METHODS
Animals: Seventy-nine albino New Zealand female 
rabbits with weights ranging from 2300 to 3200 g were 
used. The animals were kept in dedicated laboratories of the 
School of Medicine of the University of São Paulo (FMUSP) 
in cages constructed solely for the purpose of this study.
Of  the  79  animals,  33  underwent  intra-arterial 
embolization with trisacryl (Embosphere®; BioSphere® 
Medical), 31 underwent intra-arterial embolization with 
PVAc, and the remaining 15 were kept as controls. Each 
experimental group was divided into five subgroups of six 
rabbits each (n=6). The subgroups were kept captive for 
post-operative periods of either 48 hours, 5 days, 10 days, 30 
days, or 90 days. Four animals were excluded (three trisacryl 
and one PVAc) due to early deaths. The control group 
(Sham) was divided into five subgroups of three animals 
each (n=3) for the same periods of time. Within each animal, 
the non-manipulated contralateral kidney was also analyzed 
as a part of the control group.
Anesthesia: Ketamine chloridrate (Vetanarcol®, König) 
at a concentration of 20 mg/kg and xylazine chloridrate 
(Rompum®, Bayer) at a concentration of 2 mg/kg were both 
used intramuscularly. A solution of 1% lidocaine chloridrate 
( Xylocaine®, AstraZeneca) was used at the inguinal 
incision site.
Surgical Procedure: A peripheral intravenous catheter 
(Jelco®, Smiths Medical) was used for the inguinal surgical 
approach, necessitating the identification and selection 
of the right femoral artery. After the dissection, the artery 
was catheterized with a Jelco® 22G, through which a 
0.018² guidewire, and then a pediatric sheath introducer 4F 
(Cordis®, Johnson & Johnson) was placed. The animal was 
then infused with 20 mL of saline.
An angiographic catheter 4F (Cordis ®, Johnson & 
Johnson) with a hydrophilic 0.035” guidewire (Terumo®, 
Terumo Medical Corporation) was progressed through 
a catheter to the right renal artery. One milliliter of low-
osmolarity, non-ionic contrast (Optiray®, Mallinckrodt) 
was injected under fluoroscopy and an angiographic study 
was then obtained, evaluating the arterial, parenchymatous, 
and venous phases.
The intra-arterial embolization with a diameter of 100-
300 mm was carried out with a 20 mL suspension of 0.9% 
saline with either trisacryl or PVAc. Injection of the particles 
was performed slowly and under fluoroscopic control (to 
avoid possible counter-flow to the aorta) until complete 
renal artery occlusion was obtained. Devascularization 
of the kidney was confirmed with a post-embolization 
angiography, which did not show renal parenchyma 
opacification (Fig. 1). The angiographic catheter was taken 
out, hemostasia performed, and the skin was then closed 
with 4-0 monofilament Nylon (Mononylon®, Ethicon-
Johnson & Johnson) in a running suture. Intramuscular 
dipirone (Novalgina®, Aventis Pharma) and penicillin 
(Penicilina®, Pfizer) were given and the animals were sent 1107
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back to the original laboratory using ground transportation. 
The surgical procedures took place in the Interventionist 
Vascular Radiology department of the Hospital das Clínicas 
(General Hospital) of the School of Medicine of the 
University of São Paulo (FMUSP). 
The right kidney was chosen solely to maintain sample 
uniformity while the left kidney was preserved to maintain 
the vital functions of the animal until the time of sacrifice.
Sample Harvesting: The animals were sacrificed with 
an intravenous injection of sodium thiopental (Pentothal®, 
Abbott Laboratories) and potassium chloride in the 
marginal vein of the ear. The kidneys were excised (both 
the embolized and the contralateral) through a median 
laparotomy and were sectioned into two halves on the 
longitudinal (coronal) plane, photographed, and immediately 
immersed in 10% formaldehyde.
Histopathological analysis: Histopathological studies 
were undertaken in the Renal Physiopathology Research 
Laboratory (LIM-16) at the University of São Paulo with 
conventional optical microscopy. Fragments of both kidneys 
(averaging 1.0 x 1.0 cm) were taken and processed in 10% 
formol, dehydrated using increasing concentrations of 
ethylic alcohol, sheared in xylol, and immersed in paraffin 
blocks. They were then sliced into four-micron-thick slices 
and dyed by the hematoxylin-eosin (HE) and Masson’s 
trichromic methods.
The degree of vascular occlusion was evaluated as 
follows: Grade I – few particles, scarcely occluding the 
vascular lumen; Grade II – more numerous particles, 
aggregated among themselves and to the vascular wall, 
without total lumen occlusion; and Grade III – numerous 
particles, aggregated among themselves and to the vascular 
wall, with total lumen occlusion.
Necrosis of the vascular wall was classified as Grade I 
through Grade III. Grade I was assigned to lesions of up to 
25% of the vessel wall, Grade II was a lesion of up to 50% 
of the vessel wall, and Grade III included injury to more than 
50% of the vessel wall.
The degree of vascular recanalization was also classified 
as Grade I through Grade III. The recanalization was deemed 
Grade I if there were a few discrete lacunas of small caliber. 
Grade II represented moderate recanalization with more 
numerous lacunas and/or of an increased caliber. Grade III 
encompassed intense recanalization with numerous lacunas 
of a larger caliber and blood cells in the vascular lumen.
The  ischemic  necrosis  of  the  parenchyma  was 
evaluated in percentages related to the normal parenchyma 
and correlated with the number of days elapsed since 
embolization with trisacryl or PVAc.
Statistical Analysis: The non-parametric Kruskal-Wallis 
test was used through the SPSS software (Statistical Package 
for the Social Sciences, Version 8.0, Chicago, Illinois, USA, 
1977).
This study was approved by the Ethics Committee for 
the analysis of research projects of the CAPPesq of the 
Faculty of Medicine, University of São Paulo. The guidelines 
to protect the animals in the vivarium of the School of 
Medicine, University of São Paulo, were followed, as were 
the national laws for the use of animals in laboratories.
RESULTS
Both the trisacryl and the PVAc particles were injected 
with the same ease and none of the catheters clogged in 
either group.
Macroscopy: In the animals sacrificed after 48 hours of 
embolization, macroscopic study of the embolized kidneys 
showed a subcapsular cortical surface paleness and, after 
cutting, discrete blurring of the cortico-medullar limits 
associated with slight hyperemia of the medullar zone. Such 
alterations were proportionally enhanced in the five-day and 
ten-day groups, with paleness in the medullar zone and a 
complete loss of cortico-medullar limits when compared to 
the control contralateral kidneys.
After 30 and 90 days of embolization, the kidneys 
showed a decrease in longitudinal diameter of over 1.0 
cm (Fig. 2). The specimens embolized with trisacryl had 
external cortical surfaces and section surfaces similar to 
Figure 1 - Renal angiography - Arterial stage and parenchymal before and 
after embolization
Figure 2 - Macroscopic photographs of the right (embolized) kidney and the 
contralateral (control) kidney immediately after sacrificing the animal (these 
kidneys are from an animal in the 90-day post-embolization PVAc group)1108
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those observed after 10 days of embolization; however, the 
kidneys embolized with PVAc had several depressed scars 
on the cortical surface, as well as a thickened and adherent 
renal capsule. After sectioning, homogeneous areas with a 
cartilaginous appearance, as well as other areas that were 
yellowish and serpiginous, were noted.
Histopathological Study: The histological study of the 
group of rabbits after 48 hours of embolization showed that 
the trisacryl group (T) particles appeared to be flexible, often 
demonstrating a deformed aspect (Fig. 3). In contrast, the 
PVAc group (P) had a more stable spherical shape (Fig. 4).
In both groups, the particles were concentrated mainly in 
the renal hilum arteries and arcuate arteries. Some particles 
could be observed in smaller arteries (interlobular arteries), 
mainly in the T group.
There was less aggregation between the group T 
particles, which were generally found isolated in the vascular 
lumen. The P particles were found to be more aggregated, 
resulting in more vascular occlusion (p=0.1179). This 
observation was also noted in the subsequent time span 
groups. A progressive increase in the occlusion rate was 
noted in the five-day group (p=0.0068) and the ten-day 
group (p=0.0037; Table 1).
In both the trisacryl and the PVAc groups, there were 
necrotizing lesions in the walls of the obstructed vessels. 
These lesions were observed 48 hours after embolization 
(p=0.027) and were more extensive in the group of rabbits 
embolized with the PVAc particles. After 10 days, only the 
kidneys treated with PVAc particles still had vascular wall 
necrosis (Table 2).
Ten days after embolization, all group T kidneys 
presented moderate or severe recanalization of the occluded 
vessels. The group P kidneys, analyzed at the same time, 
showed no recanalization in more than half of the specimens 
studied (p=0.32). The recanalization was mild in both of the 
group P kidneys in which it was observed. After 30 days, 
predominant vascular recanalization was still observed in 
the trisacryl-treated rabbits (p=0.4073). Ninety days after 
embolization, recanalization could be observed in the renal 
vessels of both groups (p=0.2352), with no significant 
differences between them (Table 3).
Regarding the renal parenchyma, ischemic lesions and 
infarction were noted in nearly the entire extent of the 
Figure 3 - Deformed trisacryl particles and spaces left by them in the ves-
sel lumen
Figure 4 - PVA particles retain their original shape and occupy all of the 
space within the vessel
Table 1 - Vascular lumen occlusion related to the time after embolization with either trisacryl (T) or PVAc (P) 
Vascular Lumen Occlusion 
48 h 5 D 10 D 30 D
T P T P T P T P
(n=6) (n=6) (n=6) (n=6) (n=6) (n=6) (n=6) (n=5)
Grade I 2 1 3 0 4 0 0 0
Grade II 4 2 2 0 2 1 6 0
Grade III 0 3 1 6 0 5 0 5
P-values (Kruskal-Wallis p=0.1179 p=0.0068  p=0.0037 Does not apply1109
CLINICS 2009;64(11):1105-12 Effect of renal embolization with trisacryl and PAVc
Barbosa LA et al.
treated kidneys in both groups (T and P) 48 hours after 
embolization. In the animals that were sacrificed at later 
time points, the ischemic lesions and infarctions were more 
prominent in the group P rabbits, specifically 30 days after 
embolization (Table 4).
After 90 days, the kidneys of both the trisacryl and 
the PVAc groups had similar appearances. There was 
generalized fibrosis and foci of dystrophic calcification.
DISCUSSION
This study created an experimental small animal model 
(rabbit) with a long survival time to allow for an arterial 
approach to vascular system research. A microsurgery-
trained technician and adaptation of surgical tools were 
required. The mechanisms of action of the available embolic 
agents and the development of new agents have drawn the 
attention of researchers worldwide.14 Among the various 
embolic agents, non-spherical PVA particles are the most 
commonly used, with well documented biocompatibility, 
efficacy, and relative stay.1,15 Non-spherical PVA particles are 
inert and show good compatibility, elasticity, and chemical 
resistance to acids, bases, and detergents.1,16 Non-spherical 
PVA particles are susceptible to degradation over time 
(biodegradability), facilitating future recanalization of the 
treated vessels.4
In order to overcome the undesirable characteristics 
inherent to non-spherical PVA particles, different methods 
of manufacture have been attempted and other substances 
have been created and tested.7,8,11,14 The uneven shape of the 
non-spherical PVA particles available on the market appears 
to be the main reason for their aggregation and agglutination. 
Due to this problem, spherical agents have been developed. 
Among these spherical agents, trisacryl is the most widely 
utilized and best known in the literature. Spherical agents 
may not be associated with the undesirable characteristics 
of floccular particles.11,17-19 
Derdeyn et al., in an experimental study comparing 
non-spherical PVA particles and collagen-coated acrylic 
Table 2 - Vascular wall necrosis related to the number of days after embolization with trisacryl (T) or PVAc (P) 
Vascular Wall Necrosis 
48 h 5 D 10 D
T P T P T P
(n=6) (n=6) (n=6) (n=6) (n=6) (n=6)
Grade I 5 1 0 0 0 3
Grade II 1 5 4 2 0 2
Grade III 0 0 2 4 0 1
P-values (Kruskal-Wallis) p=0.027 p=0.2689 Does not apply
Table 3 - Recanalization of the vascular lumen related to the number of days after embolization with either trisacryl (T) or PVAc (P)
Recanalization of Vascular Lumen
10 D 30 D 90 D
T P T P T P
(n=6) (n=6) (n=6) (n=5) (n=5) (n=6)
0 0 4 0 1 0 0
Grade I 0 2 0 3 0 2
Grade II 3 0 2 1 3 2
Grade III 3 0 4 0 2 2
P-values (Kruskal-Wallis) p=0.32 p=0.4073 p=0.2352
Table 4 - Average percentage of parenchymal necrosis related 
to the time elapsed since embolization with either trisacryl 
(T) or PVAc (P)
Parenchymal necrosis (%)
T P
48H 100 100
5D 91.7 97
10D 76.7 93.3
30D 57.5 89.2
90D 84.2 70.81110
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microspheres (trisacryl, Embosphere®) of the same size, 
observed a significant difference in the degree of penetration 
of the particles.15 While the non-spherical PVA particles 
would often aggregate in the ascendant pharyngeal artery 
of pigs, the microspherical particles reached and flowed 
through the microcirculation. These authors suggest 
that this difference was due to the characteristics of the 
microspherical particles, including the even hydrophilic 
surface that was deformable and did not adhere to the other 
particles. The authors also stated that these characteristics 
made their injection easier and central accumulation and 
occlusion of the catheter were avoided.15 The degree of 
penetration of such non-spherical PVA particles into the 
vascular system can be affected by several factors.7 The 
labeled size of a non-spherical PVA particle refers primarily 
to its intermediate axis. The size of the intermediate axis 
allows the particle to pass through the square orifices of 
the strainer used to separate the sizes. When the vascular 
diameter is smaller than the intermediate diameter of the 
particle, the particle deforms and adapts itself to the vessel 
size.20
The PVAc particles did not obstruct any of the catheters 
used during the experiments performed in the present study. 
The PVAc particles did not present any subjective difference 
in the way they were injected compared to the trisacryl 
particle group.
Beaujeux et al. noted that microspherical particles should 
be used in larger sizes than predicted in order to achieve 
total occlusion of a given vessel during an embolization 
procedure.10 This recommendation was founded on the fact 
that the initial choice of a given particle size was based 
on the medical team’s experience with non-spherical PVA 
particles.14,20 
There is a direct correlation between the size of the 
trisacryl particles used in embolization and the diameter 
of the vessel to be occluded.21 The correlation between 
particle size and vessel diameter confirms the possibility that 
vessels can be occluded precisely depending on need. Thus, 
the use of a calibrated particle size with an exact form is 
necessary. The embolization of distal arteries has a high rate 
of necrosis. This high rate of necrosis reduces the possibility 
of revascularization in the occluded vascular territory, a 
desirable property for tumor and AVM therapies.22
The success of the PVA particles, associated with the 
benefits of their spherical configuration, has led to the 
development of spherical embolization agents consisting of 
PVA (spherical PVA).
Studies performed at the COPPE/UFRJ have led to 
the manufacture of an inert embolic agent composed of a 
thin PVA surface over a PVAc core with a spherical shape. 
These particles are also non-soluble and more resistant to 
biodegradation. These particles can be made into several 
convenient sizes and kept with a uniform, even surface and 
spherical shape in all of the studied samples of different 
diameters.13 PVAc is currently in clinical testing. Due to 
its ease of production, PVAc will come to the market at 
lower prices than trisacryl, leading to a cost decrease of 
endovascular procedures.
The higher degree of penetration found with the spherical 
PVAc particles (group P) can be beneficial for achieving a 
more effective trans-arterial embolization of many lesions. 
The higher penetration rate seen with the PVAc particles 
may be due to their uniformity and their evenly spherical, 
smooth surface.
In this study, both groups (T and P) were shown to be 
effective at achieving ischemia in the embolized kidneys 
with the development of fibrosis of the organ and a reduction 
of their longitudinal diameter. The trisacryl particles seemed 
to be more flexible and often showed a deformed aspect, 
whereas the PVAc particles were more stable in regards to 
the preservation of their initial shape. Renal embolization 
with PVAc caused a larger vascular occlusion, which was 
observed in all groups (with a significant difference in the 
5-day and 10-day post-embolization groups). This led to 
necrotizing lesions in the vessel walls, which were found 
even in the early phases (a significant difference was found 
after 48 hours) and were more extensive in the PVAc group 
than in the trisacryl group.
Recanalization of the occluded vessels embolized 
with trisacryl was also noted in a fairly extensive number 
of specimens from the 10-day post-embolization group; 
however, the PVAc analog group did not show any 
degree of recanalization in more than half of the studied 
animals. Even after 30 days, there was still predominant 
recanalization in the trisacryl group. These data suggest that 
the predominant recanalization in the trisacryl group was 
due to the larger percentage of preserved renal parenchyma, 
even though there was no statistical difference. We believe 
that recanalization in situations where necrosis is already 
established occurs due to the presence of areas of preserved 
parenchyma. Therefore, recanalization may affect the 
long-term effectiveness of embolization and encourage the 
recrudescence of the lesion.
Trisacryl particles were also found in all of the 
contralateral kidneys, a phenomenon that did not occur 
with the PVAc group. The slippery surface of the trisacryl 
particle is beneficial to the embolization procedure and 
makes them flow more easily through the catheter; however, 
this characteristic may make them more dangerous for 
practical applications. Therefore, we believe that PVAc is 
easier to control in segmental embolizations, allowing the 
preservation of some regions of the kidney. As a result, 1111
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it will be necessary to know the outcome of the clinical 
phase of research in other organs for a better assessment of 
embolization with PVAc.
In both groups, the agents (trisacryl and PVAc) were 
effective, as determined by the great deal of ischemia to the 
kidneys with subsequent acute and chronic inflammatory 
phases leading to the development of further organ fibrosis. 
Neither of the particles induced an inflammatory response 
when failing to cause a vascular occlusion. In other words, 
the particles were inert. 
The histological study showed that the PVAc particles fit 
better to the vessel walls and left behind fewer spaces to be 
filled by blood. As a result, fewer amounts of PVAc particles 
did not favor vascular recanalization.
The inflammatory reaction caused by the PVAc vascular 
occlusion was more distal and more intense than that 
caused by trisacryl particles. The inflammatory reaction in 
the PVAc-treated group promoted cellular growth into the 
vessel walls and consequent fibrosis. Thus, PVAc treatment 
rendered a recanalization event more difficult.
In  conclusion,  PVAc  particles  showed  a  higher 
degree of vascular penetration with a more intense distal 
occlusion of vessels compared to the trisacryl particles. 
The group embolized with PVAc particles showed a lower 
recanalization rate than the group embolized with trisacryl, 
despite the lack of a significant statistical difference. Both 
materials (trisacryl and PVAc) were individually effective in 
promoting necrotizing lesions in the walls of the occluded 
vessels and ischemia of the embolized kidneys, leading to 
fibrosis and reduced longitudinal diameter of the kidney.
The data obtained from this study suggest that PVAc 
is an effective embolic agent. PVAc particles are easy to 
use (do not clog catheters), possess spherical features that 
prevent particle agglutination, and are able to reach distal 
arterial segments. Ultimately, PVAc particles are able 
to promote vascular occlusion, leading to more intense 
ischemia and fibrosis and a significant reduction in the 
volume of the embolized organ.
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